SavedAdd your journal

Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 7

Changes in serum BDNF levels after treatment of panic disorder patients

Burak KULAKSIZOĞLU
Sibel KULAKSIZOĞLU
Pages
1157–1160
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum BDNF levels measured before treatment were significantly lower than BDNF levels of the control group(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Panic disorder is a significant psychiatric disorder that more frequently occurs in women, with daily attacks such as fear ofdeath, limiting the patient’s daily life.
📊
Key Findings & Data:The aim of this study was to investigate the relationshipbetween BDNF levels and the clinical features of panic disorder.Material and Methods: The study was carried out between January 2015 and July 2015 with 42 female patients and 38 healthy femaleswho were admitted to Psychiatry Outpatient Clinic.
💡
Conclusion & Impact:Serum BDNF levels measured before treatment were significantly lower than BDNF levels of the control group(p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Panic disorder is a significant psychiatric disorder that more frequently occurs in women, with daily attacks such as fear ofdeath, limiting the patient’s daily life. It is often associated with agoraphobia. The aim of this study was to investigate the relationshipbetween BDNF levels and the clinical features of panic disorder.Material and Methods: The study was carried out between January 2015 and July 2015 with 42 female patients and 38 healthy femaleswho were admitted to Psychiatry Outpatient Clinic. The patients who were diagnosed with panic disorder without agoraphobiaincluded in the study. The Panic Disorder Severity Scale (PDSS) was applied to the patients. Serum BDNF was measured by sandwichELISA.Results: The mean age of the 38 female patients was 35.1 ± 11.5 years. The mean age of the control group of 38 healthy womenwas 34.9 ± 9.82 years. Serum BDNF levels measured before treatment were significantly lower than BDNF levels measured aftertreatment (p< 0.001). Serum BDNF levels measured before treatment were significantly lower than BDNF levels of the control group(p

🔖

Cite This Article

KULAKSIZOĞLU, B., KULAKSIZOĞLU, S. (2022). Changes in serum BDNF levels after treatment of panic disorder patients. Annals of Medical Research, Cilt: 26 - Sayı: 7, 1157–1160. https://ajindex.com/articles/446708

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Pine DS, Mc Clure EB. Anksiyete bozuklukları: Klinik özellikleri. In: Aydın H, Bozkurt A, Editors. Kaplan & Sadock’s Comprehensive Text- book of Psychiatry. 8th Edition. Ankara: Güneş Kitabevi; 2007. p. 1768-71
  2. Grillon C. Anxiety Disorders. Psychophysiological Aspects. In: Sadock BJ, Sadock VA, Editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. 8th Edition. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1728- 39
  3. Bayraktar E. Panik bozukluğu ve agorafobi. Güncel Klinik Psikiyatri 2008;209-22
  4. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Rev 2004;45:104-14
  5. Javanmard M, Shlik J, Kennedy SH, et al. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol. Psychiatry 1999;45:872-82
  6. Zedkova L, Coupland NJ, Man GC, et al. Panic-related responses to pentagastrin, flumazenil, and thyrotropinreleasing hormone in healthy volunteers. Depress. Anxiety 2003;17:78-87
  7. Nutt DJ. Altered central α 2 adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989;46:165-9
  8. Papp LA, Klein DF, Martinez J. Diagnostic and substance specificity of carbon dioxide induced panic. Am J Psychiatry 1993;150:250-7
  9. Slaap BR, van Vliet IM, Westenberg HG, et al. MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report. Psychopharmacology (Berl.) 1996;127:353-8
  10. Kobayashi K, Shimizu E, Hashimoto K, et al. Serum brainderived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group behavioral therapy. Progr. Neu- ropsychopharmacol. Biol. Psychiatry 2005;29:658-63
  11. Lee IS, Kim KJ, Kang EH, et al. β-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder. Journal of affective disorders 2008;10:156-60
  12. Gul IG, Cumurcu BE, Karlidag R, et al. Ghrelin and lipid levels in panic disorder before and after treatment and their relationship with agoraphobia. Psychiatria Danubina 2015;27:250-8
  13. Lam P, Cheng CY, Hong CJ, et al. Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 2004;49:178-81
  14. Frustaci A, Pozzi G, Gianfagna F, et al. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety